| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8224525 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 7 Pages |
Abstract
For patients with HL who fail ASCT, a selective use of RT provides a durable local control rate of 65% at 2 years and should be considered as part of the standard management plan for the palliation of incurable HL. Occasionally irradiation of truly localized disease can lead to long-term survival.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jayant S. MD, Christine MSc, John MD, Mary K. MD, Woodrow MD, David C. MD, Alexander MD, Armand MD, Michael MD, Richard W. MD,